Zealand Pharma and Generate Sign AI Obesity-Drug Partnership Worth Up to Nearly $1.2 Billion
Zealand Pharma and Generate Biomedicines have entered a collaboration potentially worth nearly $1.2 billion to develop protein-based treatments for obesity...









